Regeneron Pharmaceuticals, Inc.

Healthcare · Biotechnology · United States

Last price 927.89 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 92.65B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic conditions. It also offers EYLEA injections for wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; retinopathy of prematurity; Dupixent ...